Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Mossner, Maximilian (VerfasserIn) , Jann, Johann-Christoph (VerfasserIn) , Nowak, Daniel (VerfasserIn) , Pressler, Jovita (VerfasserIn) , Obländer, Julia (VerfasserIn) , Fey, Stephanie (VerfasserIn) , Müller, Nadine Zoé (VerfasserIn) , Metzgeroth, Georgia (VerfasserIn) , Weiß, Christel (VerfasserIn) , Hofmann, Wolf-Karsten (VerfasserIn) , Nolte, Florian (VerfasserIn)
Dokumenttyp:	Article (Journal) Editorial
Sprache:	Englisch
Veröffentlicht:	27 May 2016
In:	Leukemia Year: 2016, Jahrgang: 30, Heft: 9, Pages: 1956-1959
ISSN:	1476-5551
DOI:	10.1038/leu.2016.111
Online-Zugang:	Verlag, Volltext: http://dx.doi.org/10.1038/leu.2016.111 Verlag, Volltext: http://www.nature.com/articles/leu2016111
Verfasserangaben:	M Mossner, J-C Jann, D Nowak, U Platzbecker, A Giagounidis, K Götze, A Letsch, D Haase, K Shirneshan, F Braulke, RF Schlenk, T Haferlach, P Schafhausen, G Bug, M Lübbert, A Ganser, G Büsche, E Schuler, V Nowak, J Pressler, J Obländer, S Fey, N Müller, E Lauinger-Lörsch, G Metzgeroth, C Weiß, W-K Hofmann, U Germing, and F Nolte

MARC


LEADER	00000caa a2200000 c 4500
001	1587206358
003	DE-627
005	20220815095804.0
007	cr uuu---uuuuu
008	190204s2016 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1038/leu.2016.111 \|2 doi
035			\|a (DE-627)1587206358
035			\|a (DE-576)517206358
035			\|a (DE-599)BSZ517206358
035			\|a (OCoLC)1341035118
040			\|a DE-627 \|b ger \|c DE-627 \|e rda
041			\|a eng
084			\|a 33 \|2 sdnb
100	1		\|a Mossner, Maximilian \|d 1984- \|e VerfasserIn \|0 (DE-588)1033912379 \|0 (DE-627)745111572 \|0 (DE-576)381596222 \|4 aut
245	1	0	\|a Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide \|b results from a prospective multicenter study of the german MDS study group (GMDS) \|c M Mossner, J-C Jann, D Nowak, U Platzbecker, A Giagounidis, K Götze, A Letsch, D Haase, K Shirneshan, F Braulke, RF Schlenk, T Haferlach, P Schafhausen, G Bug, M Lübbert, A Ganser, G Büsche, E Schuler, V Nowak, J Pressler, J Obländer, S Fey, N Müller, E Lauinger-Lörsch, G Metzgeroth, C Weiß, W-K Hofmann, U Germing, and F Nolte
264		1	\|c 27 May 2016
300			\|a 4
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a Gesehen am 04.02.2019
520			\|a Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)
700	1		\|a Jann, Johann-Christoph \|d 1989- \|e VerfasserIn \|0 (DE-588)1069891827 \|0 (DE-627)822939851 \|0 (DE-576)429585837 \|4 aut
700	1		\|a Nowak, Daniel \|d 1976- \|e VerfasserIn \|0 (DE-588)131932063 \|0 (DE-627)51618041X \|0 (DE-576)298844540 \|4 aut
700	1		\|a Pressler, Jovita \|d 1993- \|e VerfasserIn \|0 (DE-588)1163570788 \|0 (DE-627)1027889700 \|0 (DE-576)508058201 \|4 aut
700	1		\|a Obländer, Julia \|d 1984- \|e VerfasserIn \|0 (DE-588)1033921459 \|0 (DE-627)743670752 \|0 (DE-576)381601609 \|4 aut
700	1		\|a Fey, Stephanie \|d 1989- \|e VerfasserIn \|0 (DE-588)1163570567 \|0 (DE-627)1027889271 \|0 (DE-576)508057922 \|4 aut
700	1		\|a Müller, Nadine Zoé \|d 1981- \|e VerfasserIn \|0 (DE-588)141457082 \|0 (DE-627)627795722 \|0 (DE-576)323590365 \|4 aut
700	1		\|a Metzgeroth, Georgia \|d 1972- \|e VerfasserIn \|0 (DE-588)1051897661 \|0 (DE-627)786986832 \|0 (DE-576)407534075 \|4 aut
700	1		\|a Weiß, Christel \|d 1958- \|e VerfasserIn \|0 (DE-588)123287707 \|0 (DE-627)082463417 \|0 (DE-576)168356104 \|4 aut
700	1		\|a Hofmann, Wolf-Karsten \|d 1967- \|e VerfasserIn \|0 (DE-588)114154635 \|0 (DE-627)691208751 \|0 (DE-576)351568336 \|4 aut
700	1		\|a Nolte, Florian \|d 1976- \|e VerfasserIn \|0 (DE-588)1033390348 \|0 (DE-627)741150433 \|0 (DE-576)380987031 \|4 aut
773	0	8	\|i Enthalten in \|t Leukemia \|d London : Springer Nature, 1997 \|g 30(2016), 9, Seite 1956-1959 \|h Online-Ressource \|w (DE-627)32046699X \|w (DE-600)2008023-2 \|w (DE-576)094139733 \|x 1476-5551 \|7 nnas \|a Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide results from a prospective multicenter study of the german MDS study group (GMDS)
773	1	8	\|g volume:30 \|g year:2016 \|g number:9 \|g pages:1956-1959 \|g extent:4 \|a Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide results from a prospective multicenter study of the german MDS study group (GMDS)
856	4	0	\|u http://dx.doi.org/10.1038/leu.2016.111 \|x Verlag \|x Resolving-System \|3 Volltext
856	4	0	\|u http://www.nature.com/articles/leu2016111 \|x Verlag \|3 Volltext
951			\|a AR
992			\|a 20190204
993			\|a Editorial
994			\|a 2016
998			\|g 1033390348 \|a Nolte, Florian \|m 1033390348:Nolte, Florian \|d 60000 \|d 61200 \|e 60000PN1033390348 \|e 61200PN1033390348 \|k 0/60000/ \|k 1/60000/61200/ \|p 29 \|y j
998			\|g 114154635 \|a Hofmann, Wolf-Karsten \|m 114154635:Hofmann, Wolf-Karsten \|d 60000 \|d 61200 \|e 60000PH114154635 \|e 61200PH114154635 \|k 0/60000/ \|k 1/60000/61200/ \|p 27
998			\|g 123287707 \|a Weiß, Christel \|m 123287707:Weiß, Christel \|d 60000 \|d 60200 \|d 60250 \|e 60000PW123287707 \|e 60200PW123287707 \|e 60250PW123287707 \|k 0/60000/ \|k 1/60000/60200/ \|k 2/60000/60200/60250/ \|p 26
998			\|g 1051897661 \|a Metzgeroth, Georgia \|m 1051897661:Metzgeroth, Georgia \|d 60000 \|d 61200 \|e 60000PM1051897661 \|e 61200PM1051897661 \|k 0/60000/ \|k 1/60000/61200/ \|p 25
998			\|g 141457082 \|a Müller, Nadine Zoé \|m 141457082:Müller, Nadine Zoé \|d 60000 \|d 61200 \|e 60000PM141457082 \|e 61200PM141457082 \|k 0/60000/ \|k 1/60000/61200/ \|p 23
998			\|g 1163570567 \|a Fey, Stephanie \|m 1163570567:Fey, Stephanie \|d 60000 \|d 61200 \|e 60000PF1163570567 \|e 61200PF1163570567 \|k 0/60000/ \|k 1/60000/61200/ \|p 22
998			\|g 1033921459 \|a Obländer, Julia \|m 1033921459:Obländer, Julia \|d 60000 \|d 61200 \|e 60000PO1033921459 \|e 61200PO1033921459 \|k 0/60000/ \|k 1/60000/61200/ \|p 21
998			\|g 1163570788 \|a Pressler, Jovita \|m 1163570788:Pressler, Jovita \|d 60000 \|d 61200 \|e 60000PP1163570788 \|e 61200PP1163570788 \|k 0/60000/ \|k 1/60000/61200/ \|p 20
998			\|g 131932063 \|a Nowak, Daniel \|m 131932063:Nowak, Daniel \|d 60000 \|d 61200 \|e 60000PN131932063 \|e 61200PN131932063 \|k 0/60000/ \|k 1/60000/61200/ \|p 3
998			\|g 1069891827 \|a Jann, Johann-Christoph \|m 1069891827:Jann, Johann-Christoph \|d 60000 \|d 61200 \|e 60000PJ1069891827 \|e 61200PJ1069891827 \|k 0/60000/ \|k 1/60000/61200/ \|p 2
998			\|g 1033912379 \|a Mossner, Maximilian \|m 1033912379:Mossner, Maximilian \|d 60000 \|d 61200 \|e 60000PM1033912379 \|e 61200PM1033912379 \|k 0/60000/ \|k 1/60000/61200/ \|p 1 \|x j
999			\|a KXP-PPN1587206358 \|e 3053755084
BIB			\|a Y
SER			\|a journal
JSO			\|a {"name":{"displayForm":["M Mossner, J-C Jann, D Nowak, U Platzbecker, A Giagounidis, K Götze, A Letsch, D Haase, K Shirneshan, F Braulke, RF Schlenk, T Haferlach, P Schafhausen, G Bug, M Lübbert, A Ganser, G Büsche, E Schuler, V Nowak, J Pressler, J Obländer, S Fey, N Müller, E Lauinger-Lörsch, G Metzgeroth, C Weiß, W-K Hofmann, U Germing, and F Nolte"]},"note":["Gesehen am 04.02.2019"],"recId":"1587206358","origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"27 May 2016"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1038/leu.2016.111"],"eki":["1587206358"]},"language":["eng"],"physDesc":[{"extent":"4 S."}],"person":[{"given":"Maximilian","family":"Mossner","display":"Mossner, Maximilian","role":"aut"},{"given":"Johann-Christoph","display":"Jann, Johann-Christoph","family":"Jann","role":"aut"},{"role":"aut","given":"Daniel","display":"Nowak, Daniel","family":"Nowak"},{"given":"Jovita","family":"Pressler","display":"Pressler, Jovita","role":"aut"},{"given":"Julia","display":"Obländer, Julia","family":"Obländer","role":"aut"},{"role":"aut","given":"Stephanie","display":"Fey, Stephanie","family":"Fey"},{"given":"Nadine Zoé","family":"Müller","display":"Müller, Nadine Zoé","role":"aut"},{"family":"Metzgeroth","display":"Metzgeroth, Georgia","given":"Georgia","role":"aut"},{"role":"aut","family":"Weiß","display":"Weiß, Christel","given":"Christel"},{"given":"Wolf-Karsten","display":"Hofmann, Wolf-Karsten","family":"Hofmann","role":"aut"},{"display":"Nolte, Florian","family":"Nolte","given":"Florian","role":"aut"}],"title":[{"title_sort":"Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide","subtitle":"results from a prospective multicenter study of the german MDS study group (GMDS)","title":"Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide"}],"relHost":[{"note":["Gesehen am 15.03.04"],"pubHistory":["Nachgewiesen 11.1997 -"],"recId":"32046699X","disp":"Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide results from a prospective multicenter study of the german MDS study group (GMDS)Leukemia","part":{"issue":"9","year":"2016","extent":"4","pages":"1956-1959","text":"30(2016), 9, Seite 1956-1959","volume":"30"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia"}],"origin":[{"publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedKey":"1997"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"zdb":["2008023-2"],"issn":["1476-5551"],"eki":["32046699X"]},"language":["eng"]}]}
SRT			\|a MOSSNERMAXPREVALENCE2720

Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

MARC

Ähnliche Einträge